Author

Nita Limdi

University of Alabama

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:GWAS summary statistics· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1 Research Focus:polygenic risk· 1

Frequent Co-Authors

Chunhua WengiD· 2 shared Leah Claire KottyaniD· 2 shared Wei‐Qi WeiiD· 2 shared Yuan LuoiD· 2 shared Antonis C. AntoniouiD· 1 shared Atlas KhaniD· 1 shared Binglan LiiD· 1 shared Casey TaiD· 1 shared

Activity by Year

2022-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Chunhua WengORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Implementing Integrated Genomic Risk Assessments for Breast Cancer: Lessons Learned from the eMERGE Study

Cong Liu, Katherine D. Crew, Jennifer Morse, Jodell E. Linder, Antonis C. Antoniou, Tim J. Carver, Josh B. Cortopassi, Josh F. Peterson, Casey Ta, Christin Hoell, Cynthia A. Prows, Eimear E. Kenny, Emily Miller, Emma F. Perez, Gail Pairitz Jarvik, , Georgia L. Wiesner

The paper develops a pipeline for integrated breast cancer risk assessment using polygenic risk scores and other factors in the eMERGE study, showing high concordance between API and UI results.

medRxiv · May 22, 2025 · PreprintGenetic & Genomic Medicine

Polygenic risk vectors (PRV) improve genetic risk stratification for cardio-metabolic diseases

Ruowang Li, Xinyuan Zhang, Binglan Li, QiPing Feng, Leah Claire Kottyan, Yuan Luo, Konrad Teodor Sawicki, Atlas Khan, Nita Limdi, Megan J. Puckelwartz, Wei‐Qi Wei, Chunhua Weng, Yong Chen, Marylyn DeRiggi Ritchie, Jason H. Moore

This paper introduces polygenic risk vectors (PRV) to improve genetic risk stratification for cardio-metabolic diseases by combining additive and dominant genetic effects, outperforming traditional polygenic risk scores.

medRxiv · Mar 2, 2022 · PreprintGenetic & Genomic Medicine